(a)The commissioner shall administer this act and with
the advice of the advisory board established in W.S. 35-7-1005
may add substances to or delete or reschedule all substances
enumerated in the schedules in W.S. 35-7-1014, 35-7-1016,
35-7-1018, 35-7-1020 and 35-7-1022 pursuant to the procedures of
the Wyoming Administrative Procedure Act. In making a
determination regarding a substance, the commissioner shall
consider the following:
(i)The actual or relative potential for abuse;
(ii)The scientific evidence of its pharmacological
effect, if known;
(iii)The state of current scientific knowledge
regarding the substance;
(iv)The history and current pattern of abuse;
(v)The scope, duration, and significance of abuse;
(vi)The risk to the public health;
(vii)The potential of the substa
Free access — add to your briefcase to read the full text and ask questions with AI
(a) The commissioner shall administer this act and with
the advice of the advisory board established in W.S. 35-7-1005
may add substances to or delete or reschedule all substances
enumerated in the schedules in W.S. 35-7-1014, 35-7-1016,
35-7-1018, 35-7-1020 and 35-7-1022 pursuant to the procedures of
the Wyoming Administrative Procedure Act. In making a
determination regarding a substance, the commissioner shall
consider the following:
(i) The actual or relative potential for abuse;
(ii) The scientific evidence of its pharmacological
effect, if known;
(iii) The state of current scientific knowledge
regarding the substance;
(iv) The history and current pattern of abuse;
(v) The scope, duration, and significance of abuse;
(vi) The risk to the public health;
(vii) The potential of the substance to produce
psychic or physiological dependence liability;
(viii) Whether the substance is an immediate
precursor of a substance already controlled under this article;
and
(ix) Its other uses, both medical and commercial.
(b) After considering factors enumerated in subsection (a)
of this section, the commissioner shall make findings with
respect thereto and issue a rule controlling the substance if he
finds the substance has a potential for abuse.
(c) If the commissioner designates a substance as an
immediate precursor, substances which are precursors of the
controlled precursor shall not be subject to control solely
because they are precursors of the controlled precursor.
(d) If any substance is designated, rescheduled, or
deleted as a controlled substance under federal law the
commissioner shall control the substance under this act in the
same manner as federal law within thirty (30) days after
receiving notice of the change but not later than thirty (30)
days after the first publication of the change in the Federal
Register. Under this subsection, the commissioner shall control
the substance in the same manner as federal law through the
promulgation of an emergency rule, followed by promulgation of a
permanent rule under the Wyoming Administrative Procedure Act.
If the commissioner objects to the designation, rescheduling or
deletion of a substance, the commissioner shall within the same
period required to control the substance publish the reasons for
objection and afford all interested parties an opportunity to be
heard. At the conclusion of the hearing, the commissioner shall
publish his decision which shall be final unless altered by
statute. Upon publication of an objection to designation,
rescheduling or deletion under this act by the commissioner,
control under this act is stayed until the commissioner
publishes his final decision. Any final decision that ultimately
controls the substance under this act in the same manner as
federal law shall be finalized through the promulgation of an
emergency rule, followed by promulgation of a permanent rule
under the Wyoming Administrative Procedure Act.
(e) Authority to control under this section does not
extend to distilled spirits, wine, malt beverages, or tobacco.
(f) The commissioner shall exclude any nonnarcotic
substance from a schedule if such substance may under the
Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 301 et seq.,
and W.S. 33-24-131 of the Wyoming Pharmacy Act, be lawfully sold
over the counter without a prescription.